Mod GRF, Ipamorelin 10mg (Blend)

Mod GRF and Ipamorelin is a research peptide blend designed to explore synergistic GHRH and ghrelin receptor activation. Mod GRF (CJC-1295 no DAC) binds to the GHRH receptor, activating cAMP/PKA signaling for GH synthesis, while Ipamorelin stimulates GHS-R1a via Gq/11-mediated calcium release. This combination serves as a preclinical model for investigating peptide receptor dynamics, pulsatile secretion, and endocrine modulation.

For research use only. Not for human consumption.

References:
Teichman SL et al., J Clin Endocrinol Metab, 2006 91(2):479–487
Bowers CY et al., Endocrinology, 1990 126(2):1165–1171
Kojima M et al., Nature, 1999 402(6762):656–660